These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 9644328

  • 1. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns.
    Golub MS, Macintosh MS, Baumrind N.
    J Toxicol Environ Health B Crit Rev; 1998; 1(3):199-241. PubMed ID: 9644328
    [Abstract] [Full Text] [Related]

  • 2. Pretreatment with periodate-oxidized adenosine enhances developmental toxicity of inorganic arsenic in mice.
    Lammon CA, Le XC, Hood RD.
    Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):335-43. PubMed ID: 14666996
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in utero development.
    Stump DG, Holson JF, Fleeman TL, Nemec MD, Farr CH.
    Teratology; 1999 Nov; 60(5):283-91. PubMed ID: 10525206
    [Abstract] [Full Text] [Related]

  • 4. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms.
    Sakurai T, Kaise T, Matsubara C.
    Chem Res Toxicol; 1998 Apr; 11(4):273-83. PubMed ID: 9548797
    [Abstract] [Full Text] [Related]

  • 5. Developmental toxicity of inorganic arsenic in whole embryo: culture oxidation state, dose, time, and gestational age dependence.
    Tabocova S, Hunter ES, Gladen BC.
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):298-307. PubMed ID: 8658531
    [Abstract] [Full Text] [Related]

  • 6. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
    Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ.
    J Toxicol Environ Health A; 2004 Jan 09; 67(1):43-71. PubMed ID: 14668111
    [Abstract] [Full Text] [Related]

  • 7. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice.
    Wlodarczyk B, Spiegelstein O, Gelineau-van Waes J, Vorce RL, Lu X, Le CX, Finnell RH.
    Toxicol Appl Pharmacol; 2001 Dec 15; 177(3):238-46. PubMed ID: 11749123
    [Abstract] [Full Text] [Related]

  • 8. Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic.
    Holson JF, Desesso JM, Jacobson CF, Farr CH.
    Teratology; 2000 Jul 15; 62(1):51-71. PubMed ID: 10861633
    [Abstract] [Full Text] [Related]

  • 9. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
    Afolabi OK, Wusu AD, Ogunrinola OO, Abam EO, Babayemi DO, Dosumu OA, Onunkwor OB, Balogun EA, Odukoya OO, Ademuyiwa O.
    BMC Pharmacol Toxicol; 2015 Jun 05; 16():15. PubMed ID: 26044777
    [Abstract] [Full Text] [Related]

  • 10. Reproductive and developmental toxicity of arsenic in rodents: a review.
    Wang A, Holladay SD, Wolf DC, Ahmed SA, Robertson JL.
    Int J Toxicol; 2006 Jun 05; 25(5):319-31. PubMed ID: 16940004
    [Abstract] [Full Text] [Related]

  • 11. Effects of low-level arsenic exposure on the developmental toxicity of anilofos in rats.
    Aggarwal M, Wangikar PB, Sarkar SN, Rao GS, Kumar D, Dwivedi P, Malik JK.
    J Appl Toxicol; 2007 Jun 05; 27(3):255-61. PubMed ID: 17304642
    [Abstract] [Full Text] [Related]

  • 12. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS, Brent RL.
    Teratology; 2001 Jul 05; 64(1):51-78. PubMed ID: 11410911
    [Abstract] [Full Text] [Related]

  • 13. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans.
    Mann S, Droz PO, Vahter M.
    Toxicol Appl Pharmacol; 1996 Oct 05; 140(2):471-86. PubMed ID: 8887465
    [Abstract] [Full Text] [Related]

  • 14. Analysis of reproductive toxicity and classification of glufosinate-ammonium.
    Schulte-Hermann R, Wogan GN, Berry C, Brown NA, Czeizel A, Giavini E, Holmes LB, Kroes R, Nau H, Neubert D, Oesch F, Ott T, Pelkonen O, Robert-Gnansia E, Sullivan FM.
    Regul Toxicol Pharmacol; 2006 Apr 05; 44(3 Suppl 1):S1-76. PubMed ID: 16510221
    [Abstract] [Full Text] [Related]

  • 15. Monomethylarsonic acid and dimethylarsinic acid: developmental toxicity studies with risk assessment.
    Irvine L, Boyer IJ, DeSesso JM.
    Birth Defects Res B Dev Reprod Toxicol; 2006 Feb 05; 77(1):53-68. PubMed ID: 16496296
    [Abstract] [Full Text] [Related]

  • 16. Comparative investigations of sodium arsenite, arsenic trioxide and cadmium sulphate in combination with gamma-radiation on apoptosis, micronuclei induction and DNA damage in a human lymphoblastoid cell line.
    Hornhardt S, Gomolka M, Walsh L, Jung T.
    Mutat Res; 2006 Aug 30; 600(1-2):165-76. PubMed ID: 16764896
    [Abstract] [Full Text] [Related]

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials.
    Food Chem Toxicol; 2008 Mar 30; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation.
    Waalkes MP, Liu J, Ward JM, Diwan BA.
    Toxicology; 2004 May 20; 198(1-3):31-8. PubMed ID: 15138027
    [Abstract] [Full Text] [Related]

  • 19. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.
    Waalkes MP, Liu J, Ward JM, Diwan BA.
    Toxicol Appl Pharmacol; 2004 Aug 01; 198(3):377-84. PubMed ID: 15276417
    [Abstract] [Full Text] [Related]

  • 20. Effects of protein deficient diets on the developmental toxicity of inorganic arsenic in mice.
    Lammon CA, Hood RD.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun 01; 71(3):124-34. PubMed ID: 15282733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.